AlanHaruoBryceMD
Oncology • Goodyear, AZGenitourinary Oncology
Chief Clinical Officer, City of Hope® Cancer Center Phoenix Professor, Department of Medical Oncology & Therapeutics Research with City of Hope Professor, Department of Molecular Medicine, Translational Genomics Research Institute (TGen)
Overview of Dr. Bryce
Dr. Alan Bryce is an oncologist in Goodyear, AZ and is affiliated with City of Hope Phoenix. He received his medical degree from Chicago Medical School/Rosalind Franklin University of Medicine Science and has been in practice 16 years. Dr. Bryce accepts several types of health insurance, listed below. He is one of 27 doctors at City of Hope Phoenix who specialize in Oncology. He has more than 100 publications and over 500 citings.
Office
14200 W. Celebrate Life Way.
Goodyear, AZ 85338- Is this information wrong?
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2006 - 2009- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2003 - 2006
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2003, MD
UCLABS, Biochemistry , 1994 - 1998
Certifications & Licensure
CA State Medical License 2009 - Present
AZ State Medical License 2011 - 2025
MN State Medical License 2004 - 2009- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab Start of enrollment: 2018 Apr 24
- A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer Start of enrollment: 2018 Nov 26
- Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19 Start of enrollment: 2020 Jul 28
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsOptimal systemic therapy in men with low-volume prostate cancer.Akshat Saxena, Jack Andrews, Alan Haruo Bryce, Irbaz Bin Riaz> ;Current Opinion in Urology. 2024 May 1
- A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate canc...Mosalem, O., Tan, W., Bryce, A., Dronca, R., Childs, D., Pagliaro, L., Orme, J., Kase, A.> ;Prostate Cancer and Prostatic Diseases. 2024 Feb 10
- Challenges in clinical trials for high-risk but curable prostate cancer.Tanya Barauskas Dorff, Alan H Bryce> ;Cancer. 2024 May 1
- Join now to see all
Journal Articles
- Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients with Hereditary Cancer SyndromeScott Okuno, Luke Mountjoy, Cameron S Thorpe, Edward D Esplin, Robert L Nussbaum, Alan H Bryce, Tanios S Bekaii-Saab, Aleksandar Sekulic, JAMA Oncology
Lectures
- Patterns of PSA versus clinically progressive disease in the E3805 CHAARTED trial.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- Clinical Hematology and Oncology 2013: The 10th Annual Mayo Board ReviewMayo School of Continuous Professional Development, Scottsdale, Arizona - 1/18/2013
Press Mentions
Rucaparib Bests Physician’s Choice for BRCA+ mCRPCFebruary 23rd, 2023- Rucaparib Improves Radiographic PFS in Prostate Cancer SubgroupFebruary 16th, 2023
- Rucaparib Extends PFS in Advanced Prostate CancerOctober 8th, 2022
- Join now to see all
Hospital Affiliations
City of Hope PhoenixGoodyear, Arizona
Insurance Accepted
- BCBS Blue Card PPO
BCBS California PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPOGreat West PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
